Stacy Nobles

Corporate story-teller and dot connector; Yankee fan in Boston; driver of 3 active kids

[Stacy Nobles @StacyNobles]

Love this snapshot of my company’s why...

[Agios @AgiosPharma]

#WhyAgios? Our work matters because patients matter. You can feel the dedication at our company from our patient wall, to employees’ personal reflections on their jobs, to the great science happening in our labs. Agios is #WhereScienceMeetsHeart

[Stacy Nobles @StacyNobles]

We’ve been able to help so many patients based on who we are at our core. Looking forward to helping many more!

[Agios @AgiosPharma]

We are re-imagining The Other Side of Possible. Over the past 12+ years, our employees have been committed to patients first & following the science. This foundation will remain constant at Agios & accelerate our impact moving forward. #AgiosTomorrow https://t.co/IiuZA4E95z

[Stacy Nobles @StacyNobles]

So proud of what we’ve built at Agios and can’t wait to see what’s ahead for even more patients.

[Agios @AgiosPharma]

Today marks a transformational milestone for Agios as we move forward with a singular focus on genetically defined diseases. We are selling our oncology business to @Servier, patient-focused company committed to the cancer community. #AgiosTomorrow https://t.co/3sgiPiiSWo

[Stacy Nobles @StacyNobles]

So exciting to “ring the bell” this week (everything’s gone virtual!) in our journey to help more patients!!

[Agios @AgiosPharma]

Whenever we have exciting news for patients, we ring this bell! This is Agios tradition and we did not let the pandemic stop us from carrying it on as we celebrated our recently announced ACTIVATE Phase 3 data for people with pyruvate kinase (PK) deficiency. #AlwaysanAgioi

[Stacy Nobles @StacyNobles]

This is just embarrassing.

[Agios @AgiosPharma]

We announced clinical proof-of-concept has been established for mitapivat, our first-in class PKR activator, in sickle cell disease based on data from a Phase 1 @NIH study. https://t.co/6OnNnCfoQn

[Stacy Nobles @StacyNobles]

@HotPaperLantern @AgioS @tedbirk94 Thanks for having me — hopefully it can be face-to-face next time!

[Ken Jennings @KenJennings]

I would like to announce that when I gave wrong answers on Jeopardy, I was being sarcastic.

[Stacy Nobles @StacyNobles]

I’m confused. Is “my body, my choice” only applicable if it’s about wearing a mask / working? Does it also now apply to women’s right?

[Stacy Nobles @StacyNobles]

Really @omnimtwash, you need a doctor’s note to confirm my autoimmune issue to refund my deposit during a global pandemic?! Not sure you have the right priorities here.

[Steve Lookner @lookner]

WHY IS ANY SCHOOL OPEN IN THE U.S. RIGHT NOW

[Ana Navarro-Cárdenas @ananavarro]

I want Ruth Bader Ginsberg bubble-wrapped and kept in a sterile, vacuum-sealed room til this crap passes.

[Only In Boston @OnlyInBOS]

Massachusetts will hold its 2020 Presidential Primary Election on March 3rd.

The voter registration deadline is TODAY.

Register online to vote here: https://t.co/8wwiwydJ1w

RT TO SAVE LIVES.

[Stacy Nobles @StacyNobles]

@RexChapman And this is why the Internet is awesome.

[Stacy Nobles @StacyNobles]

Such great news — love that I am working for a company that’s making a real difference.

[Agios @AgiosPharma]

We’re pleased to announce that the Phase 3 ClarIDHy trial achieved its primary endpoint in previously treated mIDH1 cholangiocarcinoma. Thanks to all the patients & physicians who participated in the study, without whom this would not be possible. https://t.co/GjVGeiraKG

[Agios @AgiosPharma]

A big thank you to all the patients who volunteer for studies to make milestones possible – like our recent sNDA approval for newly diagnosed AML patients with an IDH1 mutation who are ineligible for intensive chemotherapy.

[Stacy Nobles @StacyNobles]

Such great news for patients.

[Agios @AgiosPharma]

#BREAKING: The @US_FDA approved the sNDA for our IDH1m inhibitor for newly diagnosed adult AML patients with an IDH1 mutation who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy https://t.co/icy82tO5e0

[Stacy Nobles @StacyNobles]

Nothing like a cupcake in the face😂

[Agios @AgiosPharma]

Why not share our love of socializing as a team, something we do every Thursday, with the kids? Thanks for following along with us! #takeourdaughtersandsonstowork #coolscience #bostonbiotech @todastw

[Agios @AgiosPharma]

“Can we do it again?” Middle schoolers also think the elephant toothpaste is cool. Science rocks! #TakeOurDaughtersandSonstoWork #futurescientists #coolscience #bostonbiotech @todastw

[Stacy Nobles @StacyNobles]

Georgi loves elephant toothpaste.

[Agios @AgiosPharma]

Negotiation and elephant toothpaste?! Direct from a visiting 3rd grader #takeourdaughtersandsonstowork #coolscience #bostonbiotech #negotiation @todastw